secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CIK:        0001801170
Form:       8-K
Filed at:   2025-05-06T23:59:59+00:00
Accession:  0001801170-25-000127
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clover Health Q1 beat: revenue $462M (+33%), Adj EBITDA $26M (+279%); raises FY guidance
--------------------------------------------------------------------------------

- Q1 total revenue $462M, up 33% YoY; GAAP net loss improved to $1M from $19M loss a year ago.
- Adjusted EBITDA $26M, up 279% YoY; Adjusted Net income $25M, up 322% YoY.
- Medicare Advantage membership 103,418, up 30% YoY; Insurance BER 86.1%.
- Full-year 2025 Adj EBITDA guidance raised to $50M-$70M from $45M-$70M; revenue outlook unchanged.
- CEO cites Clover Assistant's CHF whitepaper showing 18% lower all-cause hospitalizations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801170/000180117025000127/0001801170-25-000127-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801170/000180117025000127/clov-20250506.htm
  HTML page:      https://secwatch.observer/filing/0001801170-25-000127

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer